Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dictyostelium | 16 | 2017 | 117 | 2.040 |
Why?
|
| Computational Biology | 12 | 2016 | 874 | 1.860 |
Why?
|
| Gene Expression Profiling | 16 | 2017 | 1881 | 1.560 |
Why?
|
| User-Computer Interface | 7 | 2017 | 171 | 1.510 |
Why?
|
| Software | 10 | 2014 | 732 | 1.230 |
Why?
|
| Artificial Intelligence | 6 | 2013 | 298 | 0.880 |
Why?
|
| Database Management Systems | 4 | 2013 | 30 | 0.700 |
Why?
|
| Algorithms | 11 | 2016 | 1721 | 0.650 |
Why?
|
| Databases, Genetic | 4 | 2014 | 501 | 0.630 |
Why?
|
| Computer Graphics | 4 | 2014 | 39 | 0.590 |
Why?
|
| Models, Genetic | 6 | 2014 | 771 | 0.530 |
Why?
|
| Data Compression | 1 | 2016 | 12 | 0.500 |
Why?
|
| Internet | 5 | 2017 | 406 | 0.500 |
Why?
|
| Semantics | 1 | 2016 | 27 | 0.500 |
Why?
|
| Sequence Analysis, RNA | 4 | 2017 | 408 | 0.460 |
Why?
|
| Drug Interactions | 1 | 2016 | 246 | 0.450 |
Why?
|
| Disease | 1 | 2016 | 127 | 0.450 |
Why?
|
| Databases, Factual | 3 | 2013 | 1229 | 0.450 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 1044 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2849 | 0.410 |
Why?
|
| Models, Statistical | 2 | 2014 | 491 | 0.410 |
Why?
|
| Multigene Family | 3 | 2017 | 305 | 0.390 |
Why?
|
| Information Storage and Retrieval | 3 | 2007 | 64 | 0.390 |
Why?
|
| Genomics | 6 | 2010 | 1647 | 0.370 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 230 | 0.360 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 9 | 0.340 |
Why?
|
| Cell Differentiation | 4 | 2013 | 1960 | 0.330 |
Why?
|
| Hip Joint | 1 | 2010 | 47 | 0.330 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 167 | 0.330 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 113 | 0.280 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1828 | 0.270 |
Why?
|
| Cluster Analysis | 3 | 2017 | 430 | 0.270 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2014 | 416 | 0.270 |
Why?
|
| Protozoan Proteins | 4 | 2013 | 133 | 0.270 |
Why?
|
| Data Mining | 3 | 2013 | 60 | 0.270 |
Why?
|
| Models, Biological | 2 | 2016 | 1443 | 0.270 |
Why?
|
| Databases, Protein | 1 | 2007 | 62 | 0.270 |
Why?
|
| Biomedical Engineering | 1 | 2007 | 24 | 0.270 |
Why?
|
| Clinical Medicine | 1 | 2006 | 22 | 0.260 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 1095 | 0.250 |
Why?
|
| Statistics as Topic | 1 | 2006 | 252 | 0.240 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 198 | 0.240 |
Why?
|
| Proteome | 1 | 2007 | 279 | 0.230 |
Why?
|
| Programming Languages | 1 | 2004 | 19 | 0.220 |
Why?
|
| Genes | 1 | 2005 | 313 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 2438 | 0.220 |
Why?
|
| Gene Regulatory Networks | 4 | 2017 | 385 | 0.220 |
Why?
|
| Computer Simulation | 4 | 2014 | 697 | 0.220 |
Why?
|
| Precision Medicine | 2 | 2018 | 360 | 0.210 |
Why?
|
| Expert Systems | 1 | 2003 | 16 | 0.200 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 697 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2674 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 1017 | 0.180 |
Why?
|
| Gene Expression | 3 | 2011 | 1558 | 0.180 |
Why?
|
| Oogenesis | 2 | 2012 | 55 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 946 | 0.180 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 824 | 0.170 |
Why?
|
| Oocytes | 2 | 2012 | 290 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2011 | 4703 | 0.160 |
Why?
|
| Transcriptome | 2 | 2017 | 1122 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1657 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1799 | 0.140 |
Why?
|
| Pyrophosphatases | 1 | 2017 | 22 | 0.140 |
Why?
|
| Biomedical Research | 3 | 2008 | 553 | 0.140 |
Why?
|
| DNA, Complementary | 3 | 2013 | 454 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 236 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 47 | 0.130 |
Why?
|
| Bayes Theorem | 2 | 2016 | 311 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2016 | 55 | 0.120 |
Why?
|
| Databases, Pharmaceutical | 1 | 2016 | 5 | 0.120 |
Why?
|
| Classification | 1 | 2016 | 18 | 0.120 |
Why?
|
| Systems Integration | 1 | 2016 | 28 | 0.120 |
Why?
|
| Neoplasms | 2 | 2008 | 2955 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2016 | 120 | 0.120 |
Why?
|
| Mutation | 5 | 2013 | 6227 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2016 | 87 | 0.120 |
Why?
|
| Spores, Protozoan | 2 | 2013 | 18 | 0.120 |
Why?
|
| Probability | 1 | 2016 | 322 | 0.120 |
Why?
|
| Genome, Protozoan | 2 | 2013 | 25 | 0.110 |
Why?
|
| Epistasis, Genetic | 2 | 2005 | 102 | 0.110 |
Why?
|
| DNA Primers | 2 | 2013 | 636 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2011 | 159 | 0.110 |
Why?
|
| DNA, Fungal | 1 | 2014 | 77 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 601 | 0.110 |
Why?
|
| Animals | 12 | 2012 | 34789 | 0.100 |
Why?
|
| Wine | 1 | 2013 | 16 | 0.100 |
Why?
|
| Base Sequence | 3 | 2013 | 2899 | 0.100 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 236 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 196 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 48 | 0.100 |
Why?
|
| RNA, Protozoan | 1 | 2013 | 10 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 73 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3770 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 197 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 157 | 0.090 |
Why?
|
| Gene Library | 1 | 2013 | 213 | 0.090 |
Why?
|
| Machine Learning | 1 | 2016 | 345 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 42 | 0.090 |
Why?
|
| Biological Evolution | 2 | 2010 | 243 | 0.090 |
Why?
|
| Humans | 14 | 2018 | 131985 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 98 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2010 | 23 | 0.080 |
Why?
|
| Nucleotides | 1 | 2010 | 89 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 229 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2010 | 142 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2010 | 296 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1422 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1548 | 0.080 |
Why?
|
| Systems Biology | 1 | 2008 | 62 | 0.070 |
Why?
|
| Genome | 1 | 2011 | 504 | 0.070 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2008 | 19 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2010 | 363 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 552 | 0.070 |
Why?
|
| Crush Syndrome | 1 | 2007 | 4 | 0.070 |
Why?
|
| Rescue Work | 1 | 2007 | 11 | 0.070 |
Why?
|
| Social Behavior | 1 | 2009 | 223 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2014 | 1580 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 604 | 0.060 |
Why?
|
| Biometry | 1 | 2007 | 105 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2006 | 40 | 0.060 |
Why?
|
| Stem Cells | 1 | 2011 | 732 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 660 | 0.060 |
Why?
|
| Triage | 1 | 2007 | 149 | 0.060 |
Why?
|
| Disasters | 1 | 2007 | 106 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 803 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3608 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 1035 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 916 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 1439 | 0.050 |
Why?
|
| Knowledge | 1 | 2003 | 51 | 0.050 |
Why?
|
| Phenotype | 4 | 2014 | 4526 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 273 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2003 | 243 | 0.050 |
Why?
|
| Larva | 1 | 2003 | 260 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 742 | 0.050 |
Why?
|
| Research | 1 | 2003 | 265 | 0.050 |
Why?
|
| Genes, Protozoan | 2 | 2013 | 25 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 243 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1610 | 0.040 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 197 | 0.040 |
Why?
|
| Mice | 3 | 2012 | 18461 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 7100 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2006 | 1122 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 49 | 0.030 |
Why?
|
| DNA | 1 | 2003 | 1473 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 3736 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 215 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2017 | 301 | 0.030 |
Why?
|
| Protein Binding | 2 | 2011 | 1730 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 246 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 514 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 763 | 0.030 |
Why?
|
| United States | 2 | 2008 | 11653 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 234 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2015 | 203 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 158 | 0.030 |
Why?
|
| Middle Aged | 2 | 2010 | 28976 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2719 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 217 | 0.020 |
Why?
|
| Blastomeres | 1 | 2012 | 6 | 0.020 |
Why?
|
| Aged | 1 | 2010 | 21415 | 0.020 |
Why?
|
| Sarcoglycans | 1 | 2011 | 8 | 0.020 |
Why?
|
| Female | 4 | 2012 | 70623 | 0.020 |
Why?
|
| Muscle Development | 1 | 2011 | 73 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 261 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 236 | 0.020 |
Why?
|
| Uridine | 1 | 2010 | 32 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 459 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2010 | 20 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3678 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2010 | 66 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 2056 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 247 | 0.020 |
Why?
|
| Adult | 1 | 2010 | 31547 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1685 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 541 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2010 | 73 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 677 | 0.020 |
Why?
|
| Regeneration | 1 | 2011 | 226 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 731 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1284 | 0.020 |
Why?
|
| Education | 1 | 2008 | 111 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2697 | 0.020 |
Why?
|
| Europe | 1 | 2008 | 372 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6569 | 0.020 |
Why?
|
| Pulse | 1 | 2007 | 27 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 90 | 0.020 |
Why?
|
| Male | 2 | 2010 | 64910 | 0.020 |
Why?
|
| Tachycardia | 1 | 2007 | 69 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 764 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 157 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 249 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 180 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 32 | 0.020 |
Why?
|
| Retroelements | 1 | 2006 | 40 | 0.020 |
Why?
|
| Hyperkalemia | 1 | 2007 | 71 | 0.020 |
Why?
|
| Chromosomes | 1 | 2006 | 139 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2010 | 513 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1011 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 1280 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 119 | 0.010 |
Why?
|
| CpG Islands | 1 | 2006 | 343 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 156 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6443 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1839 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 2317 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 2493 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 3406 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 5166 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 5008 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 17391 | 0.000 |
Why?
|